Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
3.265 USD | -1.95% | -3.68% | -6.84% |
Kurzporträt
Mitarbeiterzahl: 10
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 01.09.05 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 01.12.19 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 01.01.22 |
Stephen Machatha
PRN | Corporate Officer/Principal | 47 | 01.01.21 |
James A. Gow
PRN | Corporate Officer/Principal | - | 12.03.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 01.05.09 |
Martin Joyce
BRD | Director/Board Member | 70 | 01.10.13 |
Ben Bronstein
BRD | Director/Board Member | 74 | 01.06.10 |
Todd Brady
CEO | Chief Executive Officer | 52 | 01.09.05 |
Neal Walker
BRD | Director/Board Member | 54 | 01.06.13 |
Richard Douglas
CHM | Chairman | 71 | 13.09.16 |
Director/Board Member | 65 | 13.01.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 59 414 489 | 48 657 968 ( 81,90 %) | 0 | 81,90 % |
Unternehmenskontakt
Aldeyra Therapeutics, Inc.
131 Hartwell Avenue Suite 320
02421, Lexington
+781 761 4904
http://www.aldeyra.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-6.84% | 198 Mio. | |
+16.96% | 122 Mrd. | |
+21.89% | 116 Mrd. | |
+22.18% | 27.03 Mrd. | |
-21.35% | 20.36 Mrd. | |
-16.89% | 16.43 Mrd. | |
-18.59% | 15.91 Mrd. | |
-44.74% | 15.6 Mrd. | |
+62.25% | 14.94 Mrd. | |
+2.98% | 13.59 Mrd. |
- Börse
- Aktien
- A111X8 Aktie
- Unternehmen Aldeyra Therapeutics, Inc.